• Fri, May 5, 2023
Tejas Savant Maintained (ADPT) at Hold with Decreased Target to $14 on, May 5th, 2023
Tejas Savant of Morgan Stanley, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $15 to $14 on, May 5th, 2023.
Tejas has made no other calls on ADPT in the last 4 months.
There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 0 agree with Tejas's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Tejas
- Dan Leonard of "Credit Suisse" Reiterated at Sell and Held Target at $7 on, Wednesday, February 15th, 2023
- Sung Ji Nam of "Scotiabank" Initiated at Buy and Held Target at $15 on, Thursday, January 5th, 2023
